POU5F1 and hepatocellular carcinoma: It is reported that although CD90 and OCT4 are independent and reliable biomarkers for predicting the prognosis of HCC patients after liver resection surgery, the combination of the two biomarkers can better predict the prognosis of HCC than using any one biomarker alone [34].